Use of injections in healthcare settings worldwide, 2000: literature review and regional estimates

被引:181
作者
Hutin, YJF [1 ]
Hauri, AM
Armstrong, GL
机构
[1] WHO, Dept Blood Safety & Clin Technol, Ave Appia 20, CH-1211 Geneva, Switzerland
[2] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA
来源
BMJ-BRITISH MEDICAL JOURNAL | 2003年 / 327卷 / 7423期
关键词
D O I
10.1136/bmj.327.7423.1075
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To describe injection practices worldwide in terms of frequency and safety. Design Literature review The global burden of disease project of the World Health Organization defined 14 regions on the basis of geography and mortality patterns. Data sources included published studies and unpublished WHO reports. Studies were reviewed by using a standardised decision making algorithm to generate region specific estimates. Setting Healthcare facilities, both formal and informal. Data sources: General population and users of healthcare facilities. Main outcome measure Annual number of injections per person and proportion of injections administered with syringes and needles that are reused in the absence of sterilisation. Results The analysis excluded four regions (predominantly affluent, developed nations) where reuse of injection equipment in the absence of sterilisation was assumed to be negligible. In the 10 other regions, the annual ratio of injections per person ranged from 1.7 to 11.3. Of these, the proportion administered with equipment reused in the absence of sterilisation ranged from 1.2% to 75.0%. Reuse was highest in the South East Asia region "D" (seven countries, mostly located in South Asia), the eastern Mediterranean region "D" (nine countries, mostly located in the Middle East crescent), and the western Pacific region "B" (22 countries). No information regarding injection safety was available for Latin America. Conclusions Overuse of injections and unsafe practices are still common in developing and transitional countries. An urgent need exists to use injections safely and appropriately, to prevent healthcare associated infections with HIV and other bloodborne pathogens.
引用
收藏
页码:1075 / +
页数:10
相关论文
共 65 条
  • [31] Kane A, 1999, B WORLD HEALTH ORGAN, V77, P801
  • [32] Khan AJ, 2000, B WORLD HEALTH ORGAN, V78, P956
  • [33] KO Y-C, 1991, Kaohsiung Journal of Medical Sciences, V7, P313
  • [34] KO Y-C, 1991, Kaohsiung Journal of Medical Sciences, V7, P358
  • [35] HORIZONTAL TRANSMISSION OF HEPATITIS-B VIRUS FROM SIBLINGS AND INTRAMUSCULAR INJECTION AMONG PRESCHOOL-CHILDREN IN A FAMILIAL COHORT
    KO, YC
    LI, SC
    YEN, YY
    YEH, SM
    HSIEH, CC
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1991, 133 (10) : 1015 - 1023
  • [36] KOSEN S, 1999, ASSESSMENT SAFETY EP
  • [37] Contamination of medicine injection paraphernalia used by registered medical practitioners in south India: an ethnographic study
    Lakshman, M
    Nichter, M
    [J]. SOCIAL SCIENCE & MEDICINE, 2000, 51 (01) : 11 - 28
  • [38] Logez S., 2001, ACCESSIBILITY INJECT
  • [39] The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan
    Luby, SP
    Qamruddin, K
    Shah, AA
    Omair, A
    Pahsa, O
    Khan, AJ
    McCormick, JB
    Hoodbhouy, F
    Fisher-Hoch, S
    [J]. EPIDEMIOLOGY AND INFECTION, 1997, 119 (03) : 349 - 356
  • [40] Murray Christopher J. L., 1996, The Global burden of disease: A comprehensive assesment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020